Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
Key Information
Due Date: May 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
All projects developed under this grant will contribute to the larger goals of the Cancer Tissue Engineering Collaborative Research Program. This initiative has three primary objectives. Firstly, it aims to drive progress in the development of unique, well-developed in vitro (within a glass or test tube) and ex vivo (outside of the living body) systems for research in cancer. Secondly, it seeks to broaden the scope of these systems to include a variety of cancer types for study. Lastly, the program encourages the use of biomimetic, tissue-engineered systems to explore different aspects of cancer.
Key Dates
Open Date: January 21, 2022
Application Due Date: May 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses